September 27, 2013 7:31pm
35 companies, 1 interpreter!
Insight, foresight and recommendation
6 hours 14 min ago
RegMed Investors (RMi) - Q4/23 & FY23 Cell and Gene Therapy Earnings Scorecard Results
6 hours 18 min ago
RegMed Investors (RMi) Closing Bell: a session of cell and gene therapy sector shifting share pricing
13 hours 31 min ago
RegMedInvestors (RMi) Research Note – finance: bluebird bio (BLUE)Secures up to $175 M Debt Financing with Hercules Capital
15 hours 23 min ago
RegMed Investors’ (RMi) pre-open: which way to safety?
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors